Why is Evoq Remedies falling/rising?

As of 04-Sep, Evoq Remedies Ltd is currently priced at 3.66, reflecting a decrease of 0.01, or 0.27%. The stock has been experiencing a downward trend, having lost 1.35% over the last two days. Additionally, it has shown a mixed performance in the short term, with an 18.06% increase over the past week, but a decline of 3.17% over the past month. The stock's delivery volume has significantly decreased by 56.52% compared to the 5-day average, indicating falling investor participation. Furthermore, the stock's price is currently above its 5-day moving average but below its longer-term moving averages, suggesting a lack of sustained upward momentum. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, the stock's performance over the past week has outpaced the Sensex, which only increased by 0.80%. However, over the longer term, Evoq Remedies has significantly underperformed the benchmark, with a year-to-date decline of 53.08% compared to the Sensex's gain of 3.30%. This stark contrast highlights the challenges faced by Evoq Remedies in maintaining investor confidence and market traction, especially given its substantial losses over the past year and three years.